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2 PREDICT TREATMENT OF MULTI-RESISTANT Pseudomonas aeruginosa INFECTION
Abstract. This work discloses an epidemiological mathematical model to pre-
dict an empirical treatment for dogs infected by Pseudomonas aeruginosa. This
dangerous pathogen is one of the leading causes of multi-resistant infections
and can be transmitted from dogs to humans. Numerical simulations and
appropriated codes were developed using Matlab software to gather informa-
tion concerning long-time dynamics of the susceptible, infected and recovered
individuals. All data compiled from the mathematical model was used to pro-
vide an appropriated antibiotic sensitivity panel for this specific infection. In
this study, several variables have been included in this model to predict which
treatment should be prescribed in emergency cases, when there is no time to
perform an antibiogram or the cost of it could not be assumed. In particular,
we highlight the use of this model aiming to become part of the convenient
toolbox of Public Health research and decision-making in the design of the
mitigation strategy of bacterial pathogens.
1. Introduction
Multi-drug resistant infections, typically caused by a bacterium who is resistant
to more than one antibiotic, are an emerging problem and constitute an important
threat to public health (see [1, 2, 3]), in fact, more than 700,000 people die per
year due to this kind of infections currently. Latest 2019 World Health Organiza-
tion report claims for urgent action to avert the antimicrobial resistance crisis and
highlights that, if no action is taken, drug-resistant diseases could cause 10 million
deaths each year by 2050 and damage the economy as catastrophic as the 2008-2009
global financial crisis.
In this sense, these types of infections are a defiant therapeutic challenge in both
human and veterinary medicine, due to the complex mechanisms that bacteria have
developed to resist to antibiotics and their capacity to transmit this resistance both
vertically (to their descendants) and horizontally (to other bacteria) (see [1, 2]).
In particular, Pseudomonas aeruginosa is one of the most frequent pathogen
that acquires or develops antibiotic multi-resistance. This Gram-negative rod is
very ubiquitous in the environment, can persist in water and soil with minimal
nutritional presence and can tolerate several conditions of humidity and temperature
(see [4, 5]).
Figure 1. Microscopic image of an exudate smear from the ear
canal of a dog with otitis externa. The presence of numerous rods
as well as inflammatory cells can be observed
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As revealed, this capacity to resist extreme situations as well as the high capac-
ity to develop multi-resistance after exposure to antimicrobials and cross-resistance
between agents, makes Pseudomonas aeruginosa a leading cause of nosocomial in-
fections, responsible for 10% of all hospital acquired infections. In addition, these
are often severe and life threatening, and very often very difficult to treat because
of the limited susceptibility to antimicrobial agents (see, for instance [1, 3, 4]). In
particular, in dogs this pathogen is often a cause of otitis and pyoderma. Due to
the close physical contact with their owners , dogs are a potential reservoir to multi-
resistant Pseudomonas aeruginosa, which could lead to zoonotic (animal to human)
transmission (see [5, 6, 7]).
This work compiles 40 cases of Pseudomonas aeruginosa otitis in dogs from the
south of Spain in the last five years and their susceptibility to an extended panel
of antibiotics (see Table 8 in Appendix). Although the best procedure to treat
these infections is to perform an antibiogram study, unfortunately that takes five to
seven days (see [2, 3, 4]) and not always economic resources are available, specially
in Third World Countries where sometimes the sanitary system has limited funding.
Significantly, there are some critical clinical circumstances in which the treatment
cannot be delayed due to the severity of the symptoms and the possible risk that
may lead to an irreversible situation to the patient.
Figure 2. Purulent otitis externa caused by Pseudomonas aerug-
inosa in a dog
In view of the facts described before, it would be crucial to have a powerful tool
that could help practitioners to predict the best empirical treatment possible for this
type of infection. Therefore, a professional could prescribe an antibiotic treatment
as soon as the infection is detected, in case there is no time available to perform
the antibiogram.
In this sense, the goal of the present work is to predict, using a mathematical
model, the best empirical antibiotic treatment to avoid the bacterial development
of resistance mechanisms.
The classical reference about epidemics in Mathematics is due to Kermack and
McKendrick (see [8, 9, 10]) who proposed a compartment model based on sim-
ple assumptions on the flow rates between different groups of members in some
population. Basically, the population is divided in three groups: susceptible, the
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individuals who are not infected yet but susceptible to the disease; infected, who
are the infected individuals; and recovered, individuals who have been infected in
the past and cannot be re-infected. From now on, both groups will be denoted by
S, I and R, respectively.
Since Kermanck and McKendrick proposed the so-called SIR model, many au-
thors have worked to develop innovations which improve the original SIR model in
order to describe more complex situations [11, 12]. Among these more sophisticated
models, it is worth mentioning the SIR model with relapse, or the also called SIRI
model, whose main difference compared to the SIR one is based on the the fact that
recovered individuals could be re-infected.
The SIRI model can be mathematically described with the following system of
differential equations
dS
dt
= Λ(S + I +R)− βSI − µS,(1.1)
dI
dt
= βSI − (α+ κ+ µ)I + γR,(1.2)
dR
dt
= κI − (µ+ γ)R.(1.3)
where S = S(t), I = I(t) and R = R(t) denote the number of susceptible, infected
and recovered individuals, respectively. Λ and µ are the birth and death rates of
the populations, respectively, β is the transmission coefficient of the disease, α de-
notes the death rate due to the disease, κ describes the rate at which the infected
individuals become recovered and γ is the rate at which the recovered individuals
become infected. We also remark that every constant is positive.
The different flows between the three groups of the population can be represented
as the transfer diagram in Figure 1.
Figure 3. Transfer diagram of SIRI model
To this end, we consider a population of 192 dogs of which 40 are infected and
Matlab is used to make numerical simulations and understand the long-time dynam-
ics of the different groups (susceptible, infected and recovered) of the population
depending on time. In addition, we include a code in Matlab to compute the final
number of susceptible, infected and recovered individuals in each case as well as the
time at which it happens. Therefore, we display tables and bar diagrams compiling
the information to predict the most effective antibiotics in every case.
The present work is organized as follows: Section 2compiles the materials and
methods used in this work. Section 3 shows numerical simulations of every case.
All the relevant information is depicted on tables and we use bar diagrams to reach
a better understanding of the dynamics. Section 4 provides a list of the most
suitable antibiotics to treat infected dogs. Finally, Section 5 includes conclusions
Significantly, there is a strong evidence of the utility of this type of mathematical
models performed in collaboration with other disciplines, such as health sciences.
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2. Materials and methods
For this work, forty Pseudomonas aeruginosa samples were aseptically collected
from dogs with purulent otitis externa and were sent to a specialized laboratory to
perform their culture and antibiogram analysis. We refer the reader to Table 8 in
Appendix to check the whole list of antibiotics that were tested and their rates of
resistance.
Antimicrobial susceptibility was tested using Kirby-Bauer method, also known as
disk diffusion antibiotic sensitivity testing or disk diffusion test according to Clinical
Laboratory Standards Institute (CLSI) guidelines (see [13]).
Figure 4. Antimicrobial susceptibility assay using disk diffusions
test in Pseudomonas aeruginosa culture
In addition, Matlab was used to make numerical simulations and program some
codes to obtain useful data about the behavior of the population.
3. Mathematical study. Numerical simulations and data
In this section we present the mathematical study using a SIRI model (1.1)-(1.3)
predict an empirical treatment.
The complete panel of antibiotics tested in laboratory, as well as their corre-
sponding resistance rate is presented in Table 8 in Appendix.
To organize all data obtained based on the resistance rate, the following groups
are depicted:
• Group 1- Antibiotics 100% resistant.
• Group 2- Antibiotics with resistance close to 100%.
• Group 3- Antibiotics with resistance between 30% and 50%.
• Group 4- Antibiotics with resistance between 20% and 30%.
• Group 5- Antibiotics with resistance between 10% and 20%.
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• Group 6- Antibiotics with resistance between 1% and 10%.
• Group 7- Antibiotics with resistance 0% resistant.
The percentages corresponding to the groups cited before are represented in
Figure 5.
29%
6%
6%
12%
8%
12%
27%   Resistance rate 0%
  Resistance rate 1%-10%
  Resistance rate 10%-20%
  Resistance rate 20%-30%
  Resistance rate 30%-50%
  Resistance rate close to 100%
  Resistance rate 0%
Figure 5. Resistance rates of antimicrobials
For the implementation of the model, three tools are considered essential:
• Figures (Figures 6, 8, 10, 12, 14, 16, 18) containing numerical simulations
of the SIRI model (1.1)-(1.3) with a code developed in Matlab, which will
allow to determine the dynamics of the susceptible, infected and recovered
individuals for an estimated period of time. Moreover, it allows observing
how the numbers of the different groups of our population change and its
asymptotic behavior.
• Tables (Tables 1, 2, 3, 4, 5, 6, 7) where the limit number of each group of
the population is collected for different values of the transmission coefficient
of the disease, as well as the time to reach the corresponding value. These
tables are very useful to convert the dynamics information in numerical
data. This second tool was implemented due to a code programmed in
Matlab.
• Bar diagrams (Figures 7, 9, 11, 13, 15, 17, 19) where the final number of each
group of the population is presented for different values of the transmission
coefficient of the disease.
Once the mathematical study is accomplished, it could provide practitioners an
appropriate and very convenient panel of the most effective antibiotics, which will
provide essential information in case the antibiogram is not available.
In order to develop the mathematical study, a population of 192 dogs were in-
cluded, where 40 of them are infected by Pseudomonas aeruginosa, 152 are sus-
ceptible and none of them are recovered at the initial time, considering this initial
value as zero.
Concerning the parameters in the SIRI model (1.1)-(1.3) the birth and death
rates of the population were Λ = 0 and µ = 0, assuming that no dogs were born
or died during our study. Since the average duration of this infection is considered
around 14 weeks, α = 0 since dog mortality null in this pathology. The recovery
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rate κ and the reinfection rate γ depend on the groups of antibiotics in study (see
Section 3). We remark that the transmission coefficient of the disease is unknown
but it is a rate. Therefore, every case will be studied using different values of this
parameter between 0.1 and 1.
3.1. Resistance 100%. This subsection corresponds to antibiotics with a resis-
tance rate of 100%.
In Figure 6 we display three different panels showing the dynamics of susceptible,
infected and recovered individuals, respectively. In every panel the number of mem-
bers in each group are plotted depending on time. As the initial number of dogs
in the experiment is 192 and only 40 are infected, the initial value of susceptible is
152 and the initial value of infected as 40. Noticeable, there are no recovered dogs
at the initial time.
0 days 1 days 2 days 3 days 4 days 5 days 6 days 7 days
0 dogs
50 dogs
100 dogs
150 dogs
Dynamics of susceptible individuals
0 days 1 days 2 days 3 days 4 days 5 days 6 days 7 days
0 dogs
50 dogs
100 dogs
150 dogs
Dynamics of infected individuals
0 days 1 days 2 days 3 days 4 days 5 days 6 days 7 days
0 dogs
50 dogs
100 dogs
150 dogs
Dynamics of recovered individuals
Figure 6. Dynamics of susceptible, infected and recovered indi-
viduals depending on time (in days) when using an antibiotic with
a resistance rate of 100%
In Table 1 the number of susceptible, infected and recovered individuals at the
final time is depicted for different values of the transmission coefficient of the disease
β. For instance, when β = 0.1 the limit of susceptible individuals is 0.9892 and this
limit is reached after 6.1075 days. The limit of infected individuals is 186.0153 and
it is reached after 5.3200 days and, finally, the number of susceptible individuals
remains constant zero during all the time.
In Table 1 we can notice that most of dogs will be infected in approximately 5
days and no dogs will be recovered corresponding to a 100% resistance rate.
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Susceptibles Infected Recovered
Time (days) Individuals Time (days) Individuals Time (days) Individuals
β = 0.1 6.1075 0.9892 5.3200 186.0153 0.0000 0.0000
β = 0.2 3.0450 0.9997 2.8175 185.0218 0.0000 0.0000
β = 0.3 2.0300 0.9911 1.8200 183.0880 0.0000 0.0000
β = 0.4 1.5225 0.9821 1.4525 182.0727 0.0000 0.0000
β = 0.5 1.2250 0.9368 1.1025 180.0496 0.0000 0.0000
β = 0.6 1.0150 0.9635 0.9800 179.0448 0.0000 0.0000
β = 0.7 0.8750 0.9183 0.7875 177.0125 0.0000 0.0000
β = 0.8 0.7700 0.8748 0.7350 176.0281 0.0000 0.0000
β = 0.9 0.6825 0.8819 0.6125 174.0724 0.0000 0.0000
β = 1 0.6125 0.8888 0.5950 173.1766 0.0000 0.0000
Table 1. Data for different values of the transmission coefficient
of the disease β in case of using antibiotics with a resistance rate
of 100%
Based on Table 1 we present in Figure 7 a bar diagram to to illustrate the results
obtained.
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Figure 7. Time (days) to reach the limit number of susceptible,
infected and recovered individuals for different values of the trans-
mission coefficient of the disease in case of using antibiotics with a
resistance rate of 100%
In order to avoid redundancies, in the following cases we will present the different
figures following the structure presented before.
3.2. Resistance close to 100%. This subsection corresponds to antibiotics with
a resistance rate close to 100%. Due to the similarities of the rates among the
antibiotics of this group, Amoxicillin and Clavulanic acid has been considered to be
representative, with a resistance rate of 97.50%.
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Figure 8. Dynamics of susceptible, infected and recovered indi-
viduals depending on time (in days) when using an antibiotic with
resistance 97.50%
Susceptibles Infected Recovered
Time (days) Individuals Time (days) Individuals Time (days) Individuals
β = 0.1 6.2475 0.9857 5.5475 182.0012 1.9775 3.0085
β = 0.2 3.1150 0.9875 2.9400 181.0199 1.0675 3.0005
β = 0.3 2.0825 0.9541 1.8725 179.0799 0.7700 3.0049
β = 0.4 1.5575 0.9571 1.4875 178.0629 0.6300 3.0395
β = 0.5 1.2425 0.9603 1.1200 176.1075 0.5425 3.0513
β = 0.6 1.0325 0.9637 0.9800 175.0559 0.4900 3.0900
β = 0.7 0.8925 0.8982 0.7875 173.1549 0.4375 3.0372
β = 0.8 0.7700 0.9709 0.7175 172.1004 0.4025 3.0154
β = 0.9 0.6825 0.9746 0.5950 170.2078 0.3850 3.0559
β = 1 0.6125 0.9783 0.5425 169.0158 0.3675 3.0651
Table 2. Data for different values of the transmission coefficient
of the disease β in case of using antibiotics with a resistance rate
of 97.50%
10 PREDICT TREATMENT OF MULTI-RESISTANT Pseudomonas aeruginosa INFECTION
β = 0.1 β = 0.2 β = 0.4 β = 0.6 β = 0.8 β = 1
0
2
4
6
6
.2
5
3
.1
2
1
.5
6
1
.0
3
0
.7
7
0
.6
1
5
.5
5
2
.9
4
1
.4
9
0
.9
8
0
.7
2
0
.5
4
1
.9
8
1
.0
7
0
.6
3
0
.4
9
0
.4
0
0
.3
7
Transmission coefficient of the disease
T
im
e
(d
a
y
s)
Susceptibles
Infected
Recovered
Figure 9. Time (days) to reach the limit number of susceptible,
infected and recovered individuals for different values of the trans-
mission coefficient of the disease when an antibiotic with a resis-
tance rate of 97.50% is prescribed
3.3. Resistance 30%-50%. This subsection corresponds to the group of antibi-
otics with a resistance rate between 30% and 50%. Among all the antibiotics in-
cluded, Enrofloxacin, with a resistance rate of 34,21%, is used as an example.
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0 dogs
50 dogs
100 dogs
150 dogs
Dynamics of susceptible individuals
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Figure 10. Dynamics of susceptible, infected and recovered indi-
viduals depending on time (in days) when using an antibiotic with
a resistance rate of 34.21% is prescribed
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Susceptibles Infected Recovered
Time (days) Individuals Time (days) Individuals Time (days) Individuals
β = 0.1 16.9575 0.9994 12.8275 64.0028 14.5075 124.0053
β = 0.2 8.1025 0.9991 6.0375 64.0011 7.3850 124.0110
β = 0.3 5.1975 0.9824 3.1325 63.0067 4.4975 123.0316
β = 0.4 3.7450 0.9942 2.0475 63.0236 3.5525 123.0152
β = 0.5 2.9050 0.9703 1.2250 63.0482 2.6425 122.0149
β = 0.6 2.3450 0.9633 0.5250 62.2112 2.0825 121.0022
β = 0.7 1.9425 0.9752 0.3150 62.8271 1.9775 121.0016
β = 0.8 1.6450 0.9842 0.2100 62.7526 1.6625 120.0108
β = 0.9 1.4175 0.9882 1.5225 62.9793 1.4525 119.0726
β = 1 1.2425 0.9731 0.1225 62.8659 1.2775 118.0144
Table 3. Data for different values of the transmission coefficient
of the disease β when an antibiotic with a resistance rate of 34.21%
is used
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Figure 11. Time (days) to reach the limit number of suscepti-
ble, infected and recovered individuals for different values of the
transmission coefficient of the disease when an antibiotic with a
resistance rate of 34.21% is prescribed
3.4. Resistance 20%-30%. This subsection is focused in the group of antibiotics
with a resistance rate between 20 and 30 Gentamicin, with a resistance rate of
23.68%, has been chosen as an example.
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Figure 12. Dynamics of susceptible, infected and recovered in-
dividuals depending on time (in days) when an antibiotic with a
resistance rate of 23.68% is used
Susceptibles Infected Recovered
Time (days) Individuals Time (days) Individuals Time (days) Individuals
β = 0.1 17.4475 5.9890 13.8425 42.0097 16.5375 139.0219
β = 0.2 11.6025 0.9932 6.8075 43.0015 10.2375 143.0048
β = 0.3 7.3500 0.9962 3.9025 43.0159 6.9300 143.0074
β = 0.4 5.2675 0.9891 2.3450 43.0155 4.6900 142.0205
β = 0.5 4.0425 0.9787 1.1025 43.0038 3.9900 142.0091
β = 0.6 3.2200 0.9987 0.1925 43.2377 3.0625 141.0019
β = 0.7 2.6600 0.9864 0.0525 42.0490 2.4675 140.0001
β = 0.8 2.2400 0.9866 0.0350 42.6969 2.0650 139.0233
β = 0.9 1.9250 0.9699 0.0175 42.2403 1.7675 138.0169
β = 1 1.6625 0.9865 0.0175 43.3302 1.5575 137.0543
Table 4. Data for different values of the transmission coefficient
of the disease β when an antibiotic with a resistance rate of 23.68%
is evaluated
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Figure 13. Time (days) to reach the limit number of susceptible,
infected and recovered individuals for different values of the trans-
mission coefficient of the disease in case of using antibiotics with a
resistance rate of 23.68%
3.5. Resistance 10%-20%. In this subsection the antibiotics with a resistance
rate between 10% and 20% are studied. In this case, Tobramycin, with a resistance
rate of 15,15% has been considered as an example.
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Figure 14. Dynamics of susceptible, infected and recovered indi-
viduals depending on time (in days) when using an antibiotic with
a resistance rate of 15.15%
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Susceptibles Infected Recovered
Time (days) Individuals Time (days) Individuals Time (days) Individuals
β = 0.1 33.2850 1.9970 23.6075 28.0021 30.7300 157.0074
β = 0.2 17.6050 0.9952 10.1500 28.0028 16.3275 158.0060
β = 0.3 11.0775 0.9917 5.6175 28.0040 9.5200 157.0011
β = 0.4 7.8575 0.9982 3.2025 28.0095 7.1575 157.0100
β = 0.5 5.9850 0.9881 0.6300 28.9433 5.1625 156.0244
β = 0.6 4.7425 0.9984 2.8350 28.9999 4.5325 156.0066
β = 0.7 3.8850 0.9942 2.5200 28.9953 3.6050 155.0242
β = 0.8 3.2550 0.9880 2.1175 28.9973 2.9575 154.0025
β = 0.9 2.7650 0.9933 1.8025 28.9944 2.5200 153.0369
β = 1 2.3800 0.9956 1.5750 28.9719 2.1875 152.0432
Table 5. Data for different values of the transmission coefficient
of the disease β in case of using antibiotics with a resistance rate
of 15.15%
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Figure 15. Time (days) to reach the limit number of susceptible,
infected and recovered individuals for different values of the trans-
mission coefficient of the disease in case when an antibiotic with
resistance rate of 15.15% is used
3.6. Resistance 1%-10%. This subsection studies the group of antibiotics with a
resistance rate between 1% and 10%. Imipenem, with a resistance rate of 7,14% is
considered representative.
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Figure 16. Dynamics of susceptible, infected and recovered in-
dividuals depending on time (in days) when an antibiotic with a
resistance rate of 7.14% is assayed
Susceptibles Infected Recovered
Time (days) Individuals Time (days) Individuals Time (days) Individuals
β = 0.1 34.7375 30.9964 25.6550 10.0024 34.2650 144.0183
β = 0.2 33.4250 1.9991 15.4875 12.0004 30.4500 171.0015
β = 0.3 23.6775 0.9966 7.5425 12.0045 21.0700 172.0027
β = 0.4 16.6600 0.9966 3.3425 12.0015 15.4700 172.0035
β = 0.5 12.5475 0.9978 0.9975 13.9876 10.7975 171.0122
β = 0.6 9.8875 0.9940 1.6275 13.9938 9.2575 171.0008
β = 0.7 8.0325 0.9916 1.9950 13.9923 7.1750 170.0007
β = 0.8 6.6675 0.9927 1.9600 13.9912 5.8100 169.0100
β = 0.9 5.6350 0.9884 1.8025 13.9858 4.8475 168.0026
β = 1 4.8125 0.9920 5.9500 12.9997 4.1650 167.0077
Table 6. Data for different values of the transmission coefficient
of the disease β in case of using antibiotics with a resistance rate
of 7.14%
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Figure 17. Time (days) to reach the limit number of susceptible,
infected and recovered individuals for different values of the trans-
mission coefficient of the disease in case of using antibiotics with a
resistance rate of 7.14%
3.7. Resistance 0%. This subsection corresponds to the antibiotics with total
effectiveness.
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Figure 18. Dynamics of susceptible, infected and recovered in-
dividuals depending on time (in days) when an antibiotic with a
resistance rate of 0% is used
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Susceptibles Infected Recovered
Time (days) Individuals Time (days) Individuals Time (days) Individuals
β = 0.1 0.4375 145.9988 0.7000 0.9824 0.5950 39.0306
β = 0.2 0.8225 136.9863 0.8400 0.9809 0.8050 48.0938
β = 0.3 0.9100 125.9459 1.0150 0.9564 0.9450 59.0773
β = 0.4 1.4875 110.9878 1.1900 0.9695 1.3125 74.0443
β = 0.5 1.3825 94.9995 1.3300 0.9970 1.4525 90.0654
β = 0.6 1.6800 77.9836 1.4175 0.9886 1.4875 106.0461
β = 0.7 1.6275 62.9900 1.4350 0.9982 1.4175 120.0633
β = 0.8 2.6425 49.9998 1.4175 0.9869 1.4175 132.0735
β = 0.9 1.7850 39.9951 1.3825 0.9673 1.3300 141.0661
β = 1 1.6975 31.9943 1.3300 0.9899 1.2775 148.0393
Table 7. Data for different values of the transmission coefficient
of the disease β in case of using antibiotics with resistance 0%
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Figure 19. Time (days) to reach the limit number of susceptible,
infected and recovered individuals for different values of the trans-
mission coefficient of the disease in case of using antibiotics with a
resistance rate of 0%
4. Results and discussions
This study includes a group of 192 dogs affected by otitis externa living in the
south of Spain, in which 40 individuals were infected by Pseudomonas aeruginosa.
All samples were aseptically collected and sent to a laboratory to to perform an
antibiogram that included 52 different antibiotics.
We recall that the goal of this work was to develop an antibiotic panel that could
be used as an empirical treatment for dogs infected with Pseudomonas aeruginosa,
a pathogen transmissible to humans, with high multi-resistance capacities and that
is considerate the leading cause of nosocomial infections in human medicine. To this
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end, the well-known SIRI model (1.1)-(1.3) was used which helped us to provide a
priority antibiotic treatment.
In this way, the behavior of the different groups of individuals of the population
of dogs infected by Pseudomonas aeruginosa was studied using the SIRI model to
observe the dynamics of every group. In addition a code was programmed in Matlab
to obtain the most relevant information from these simulations and then, they were
represented in a table where the limit value of susceptible, infected and recovered
individuals were included as well as the time at which the corresponding limits were
reached.
The SIRI model (1.1)-(1.3) reunited all the necessary characteristics and, after
comparing with the possible application of other mathematical models, this is the
one that was the most suitable and accurate relating to all the epidemiological data
compiled as well as to clinical behavior of the infection. To our knowledge, this is
the firs time this specific application of the model is described relating to pathogenic
microorganisms dynamics.
Especially, it is worth mentioning that this work is quite relevant for mathe-
matical science, since it proves that mathematical modelling should become part
of the convenient toolbox of Public Health research and decision-making, specially
in the design of models of empirical treatment choices based on epidemiological data.
Interestingly, results show that a significant number of antibiotics tested (27,45%)
have null action to Pseudomonas aeuruginosa infection. In addition, it is remark-
able to add that some of them are third generation Cephalosporins (more specific
and expensive, with a more complex development). Moreover, approximately 12%
of the antibiotics included had a resistance rate of almost 100% and 8% of them
between 50% and 30%. Hence, when an empirical antibiotic treatment is provided,
the chance of ineffectiveness or partial effect (which is one of the causes that in-
creases the resistance rate) is, at least, 30%.
This fact highlights the potential health problem that presents this multi-resistant
microorganisms and the necessity of an accurate tool to prescribe the most specific
and effective treatment. On the other hand, almost a third part of the total of
antibiotic tested were always effective, however the use of a high number of them
are hospital restricted.
Regarding the results obtained, we consider that the SIRI model implemented in
the present work can be a very useful tool to predict the dynamic of Pseudomonas
aeruginosa infection in dogs, since it provides an antibiotic panel that in case is
empirically prescribed, it has an accuracy of efficacy of more than 90% (Figure 20)
. Subsequently, it can be used as an efficient model to formulate potential per-
sonalized treatment in both human and veterinary medicine, in order not only to
save cost, but also to avoid future problems of development of multi-resistance by
this bacteria in both humans and animals, because its high level of specificity and
efficacy against the infection.
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Although all the antibiotics included in the recommended panel have an efficacy
of more than 90%, the use of most of them are hospital-restricted, which could
present, in this concrete infection and microorganism, a problem in prescribing the
treatment in some clinical situations.
The results obtained are in consonance with the epidemiological data and the
information that the World Health Organization, as well as numerous Epidemio-
logical Health Services, in human and veterinary medicine, are providing. Conse-
quently, the present work highlights the severity of the multi-resistance development
in pathogens and reinforces the necessity of new tools to implement in the strategies
that have to be applied.
Figure 20 provides a selective antibiotic panel in case is necessary to prescribe
an efficient empirical treatment to Pseudomonas aeruginosa infection.
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Miscellaneous Colistin
Tetracyclines Tigecyclin
Quinolones
Maxifoxacin
Lome foxacin
Oxonilic acid
Levofoxacin
Aminoglycosides
Amykacin
Estrptomycin
Sisomycin
Kanamycin
Beta lactam antibiotics
Penicilins
Piperacilin
Ticarcilin
Penicilin G
Carbapenem
Meropenen
Imipenem
Pipe-tazobactam
Cefquinome
Cefoperazone
Ceftazidime
Antibiotic families Antibiotic subfamilies Treatment
Figure 20. Antibiotic panel recommended to prescribe an empir-
ica treatment against Pseudomonas aeruginosa infection in Spain
5. Conclusions
Multi-resistant infections are an unequivocal public health problem and are re-
sponsible for an increasing number of deceased patients in hospitals. In this sense,
companion animals can act as a reservoir of this type of microorganisms that can
be transmitted to humans.
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At this point, since no studies of these characteristics have been previously de-
scribed, it is urgent and critical to develop an efficient tool to minimize the antimi-
crobial resistance process. Therefore, we have applied an adapted SIRI model as a
compatible and potential tool based on Matlab software. Remarkably, this model
allows predicting the behavior of Pseudomonas aeruginosa infection and is essential
to select an effective empirical treatment when culture and antibiogram techniques
are no available or the severity of the infection obliges an imminent treatment, pro-
viding an antibiotic panel with an accuracy of efficacy of more than 90%.
Our study suggest that this method could be suitable to be used in other in-
fections therapies in other microorganisms and in other countries based on their
epidemiological data. Furthermore, it is likely to reinforce the accuracy to provide
a more effective treatment of choice, using a model that behaves as a very useful
tool to be implemented in Public Health research and decision-making strategies.
Appendix
In Appendix we provide the table of antibiotics tested as a treatment.
Group Antibiotic Resistance (rate)
Beta lactam Cephalosporins Cefalotin 100%
antibiotics Ceftazidime 16,67%
Cefotaxime 47,37%
Cefepime 21,05%
Cefoxitin 100%
Cefuroxime 100%
Cefazolin 100%
Ceftazidime/CA 82,35%
Cefovecin 95,24%
Cefalexin 100%
Cefotaxime/CA 100%
Ceftiofur 100%
Cefpodoxime 100%
Cefoperazone 0%
Cefquinome 0%
Beta lactamase Amoxicilin clav. 97,50%
inhibitors Ampicilin 100%
Piperacillin-tazobactam 5,88%
Carbapenem Imipenem 7,14%
Ertapenem 53,85%
Meropenem 0%
Monobactams Aztreonam 20,69%
Penicilins Piperacillin 0%
Ticarcillin 0%
Penicillin 0%
Aminoglycosides Tobramycin 15,15%
Gentamicin 23,68%
Amikacin 6,25%
Neomycin 50%
Continue in the next page
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Group Antibiotic Resistance (rate)
Kanamycin 0%
Sisomicin 0%
Streptomycin 0%
Quinolones Ciprofloxacin 28,57%
Enrofloxacin 34,21%
Marbofloxacin 23,81%
Nalidixic acid 93,33%
Pradofloxacin 28,57%
Levofloxacin 0%
Oxolinic acid 0%
Maxifloxacin 0%
Lomefloxacin 0%
Tetracyclines Doxycycline 92,86%
Tetracycline 83,33%
Tigecycline 0%
Afenicol Chloramphenicol 100%
Florfenicol 100%
Miscellaneous Polymyxin B 15,79%
Colistin 0%
Fusidic acid 100%
Fosfomycin 100%
Macrolide Erythromycin 33,33%
Sulfamide Sulfonamides+Trimethoprim 100%
Table 8: Table of all the antibiotics assayed in the antibiograms
included in the study
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